Prenatal diagnosis of Hartsfield syndrome with a novel genetic variant.


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
27 Nov 2023
Historique:
revised: 12 10 2023
received: 30 08 2023
accepted: 04 11 2023
medline: 28 11 2023
pubmed: 28 11 2023
entrez: 28 11 2023
Statut: aheadofprint

Résumé

A G2P0, 24-year-old woman presented at 17 weeks 3 days gestation for a fetal anatomy scan. Ultrasound identified bilateral upper and lower extremity ectrodactyly, semilobar holoprosencephaly, midface hypoplasia, and cleft lip and palate. Amniocentesis for a chromosome microarray demonstrated no significant copy number changes. Whole exome sequencing was subsequently completed, which revealed a de novo, likely pathogenic variant in FGFR1, c.2044G>A (D682N), consistent with FGFR1-related Hartsfield syndrome. This case highlights the first presumed molecularly confirmed prenatal diagnosis of Hartsfield syndrome and identifies a new pathogenic variant.

Identifiants

pubmed: 38013637
doi: 10.1002/pd.6472
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 John Wiley & Sons Ltd.

Références

Simonis N, Migeotte I, Lambert N, et al. FGFR1 mutations cause Hartsfield syndrome, the unique association of holoprosencephaly and ectrodactyly. J Med Genet. 2013;50(9):585-592. https://doi.org/10.1136/jmedgenet-2013-101603
Takenouchi T, Okuno H, Kosaki R, et al. Microduplication of Xq24 and Hartsfield syndrome with holoprosencephaly, ectrodactyly, and clefting. Am J Med Genet A. 2012;158A(10):2537-2541. https://doi.org/10.1002/ajmg.a.35465
Courage C, Jackson CB, Owczarek-Lipska M, et al. Novel synonymous and missense variants in FGFR1 causing Hartsfield syndrome. Am J Med Genet A. 2019;179(12):2447-2453. https://doi.org/10.1002/ajmg.a.61354
Kobayashi S, Tanigawa J, Kondo H, et al. Endocrinological features of Hartsfield syndrome in an adult patient with a novel mutation of FGFR1. J Endocr Soc. 2020;4(5):bvaa041. https://doi.org/10.1210/jendso/bvaa041
Hong S, Hu P, Marino J, et al. Dominant-negative kinase domain mutations in FGFR1 can explain the clinical severity of Hartsfield syndrome. Hum Mol Genet. 2016;25(10):1912-1922. https://doi.org/10.1093/hmg/ddw064
Harris E, Richardson R, Annavarapu S, et al. Mosaicism in Hartsfield syndrome. Eur J Med Genet. 2022;65(5):104491. https://doi.org/10.1016/j.ejmg.2022.104491

Auteurs

Matthew Rich (M)

Baystate Medical Center, Springfield, Massachusetts, USA.
UMass Chan Medical School, Worcester, Massachusetts, USA.

Bradley Schroeder (B)

Baystate Medical Center, Springfield, Massachusetts, USA.
UMass Chan Medical School, Worcester, Massachusetts, USA.

Courtney Manning (C)

Baystate Medical Center, Springfield, Massachusetts, USA.
UMass Chan Medical School, Worcester, Massachusetts, USA.

Mary-Alice Abbott (MA)

Baystate Medical Center, Springfield, Massachusetts, USA.
UMass Chan Medical School, Worcester, Massachusetts, USA.

Classifications MeSH